|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Fusion Pharmaceuticals (NASDAQ: FUSN) through any online brokerage.
The latest price target for Fusion Pharmaceuticals (NASDAQ: FUSN) was reported by Morgan Stanley on May 18, 2021. The analyst firm set a price target for 20.00 expecting FUSN to rise to within 12 months (a possible 147.83% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Fusion Pharmaceuticals (NASDAQ: FUSN) is $8.07 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Fusion Pharmaceuticals.
There is no upcoming split for Fusion Pharmaceuticals.
Fusion Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.